Literature DB >> 17936892

Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.

Benedetta Belloni, Mahzad Ziai, Annick Lim, Brigitte Lemercier, Martin Sbornik, Stephan Weidinger, Christian Andres, Christina Schnopp, Johannes Ring, Rüdiger Hein, Markus Ollert, Martin Mempel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936892     DOI: 10.1016/j.jaci.2007.08.060

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  29 in total

Review 1.  Therapeutic perspectives in atopic dermatitis.

Authors:  Laurent Misery
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

2.  Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria.

Authors:  Ravi K Viswanathan; Mark H Moss; Sameer K Mathur
Journal:  Allergy Asthma Proc       Date:  2013 Sep-Oct       Impact factor: 2.587

3.  Omalizumab for patients with severe and therapy-refractory atopic eczema?

Authors:  Christian Andres; Benedetta Belloni; Martin Mempel; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2008-05       Impact factor: 4.806

Review 4.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

5.  New insights into the utility of omalizumab.

Authors:  Juan Carlos Cardet; Thomas B Casale
Journal:  J Allergy Clin Immunol       Date:  2019-01-26       Impact factor: 10.793

6.  Successful treatment of a patient with severe atopic dermatitis and severe asthma by centrifugal therapeutic plasma exchange.

Authors:  Louise Fuller; Benit Maru; Neil Isserlis; Rino Cerio
Journal:  BMJ Case Rep       Date:  2015-05-12

Review 7.  IgE, mast cells, and eosinophils in atopic dermatitis.

Authors:  Fu-Tong Liu; Heidi Goodarzi; Huan-Yuan Chen
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

Review 8.  Omalizumab: Anti-IgE therapy in allergy.

Authors:  Matthias Volkmar Kopp
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

9.  [Status quo and prospects for systemic therapy of atopic dermatitis. Biologics ante portas].

Authors:  T Biedermann; T Werfel
Journal:  Hautarzt       Date:  2015-02       Impact factor: 0.751

Review 10.  Therapies for allergic inflammation: refining strategies to induce tolerance.

Authors:  Cezmi A Akdis
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.